Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy.

Evid Based Complement Alternat Med

State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China.

Published: May 2022

Background: Danshen Decoction comprises , , and . It can promote blood circulation and remove blood stasis, and is commonly used in the treatment of gastric and duodenal ulcers, coronary heart disease, angina pectoris, etc. This research is based on network pharmacology and is experimentally verified to explore the potential mechanism of Danshen Decoction in the treatment of ischemic cardiomyopathy (ICM).

Methods: The effective components and targets of Danshen Decoction were firstly extracted from Traditional Chinese Medicine Systems Pharmacology (TCMSP) Database and Analysis Platform, the drug-component-target-disease network was then constructed, the protein-protein interaction (PPI) network was constructed, the Gene Ontology (GO) enrichment analysis was carried out, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was analyzed in order to find the potential active components and therapeutic mechanisms. Finally, the hypoxia/reoxygenation model in H9c2 cells was established to verify the predicted active components and therapeutic mechanisms.

Results: The results showed that Danshen Decoction has 67 potential active components and 109 therapeutic targets in treating ICM. These targets were rich in a variety of gene functions and different signaling pathways; the main gene targets include TP53, c-Jun, and Akt1. Go enrichment analysis showed that response to drug, membrane raft, and G protein-coupled amine receiver activity rank first in each process, and the main signaling pathways include PI3K-Akt signaling pathway. Through molecular docking and experimental verification of the major active components and core therapeutic targets, the active components of Danshen Decoction demonstrated an ability to reduce the cell damage caused by hypoxia/reoxygenation in H9c2 cells by regulating the core therapeutic target including Akt1, c-Jun, and TP53.

Conclusion: Danshen Decoction has the effect of treating ICM in multiple ways, which is consistent with the results of network pharmacology. This laid a foundation for further study in exploring the active principles and pharmacological mechanism of Danshen Decoction.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205745PMC
http://dx.doi.org/10.1155/2022/7578055DOI Listing

Publication Analysis

Top Keywords

danshen decoction
32
active components
20
network pharmacology
12
mechanism danshen
12
experimental verification
8
danshen
8
decoction
8
decoction treating
8
ischemic cardiomyopathy
8
network constructed
8

Similar Publications

Introduction: Taohong Siwu decoction (THSWD), a traditional prescription for enhancing blood circulation and eliminating blood stasis, primarily comprises peach kernel, safflower, angelica, chuanxiong, and rehmannia. Modified Taohong Siwu decoction (MTHSWD), an advanced version of THSWD, incorporates additional ingredients such as epimedium, cinnamon, and salvia miltiorrhiza. This addition serves to augment its efficacy in warming yang and promoting blood circulation.

View Article and Find Full Text PDF

Background: Astragalus mongholicus (AM) and Salvia miltiorrhiza (SM) are commonly used in traditional Chinese medicine to treat heart failure (HF). Ferroptosis has been studied as a key factor in the occurrence of HF. It remains unclear whether the combined use of AM and SM can effectively improve HF and the underlying mechanisms.

View Article and Find Full Text PDF

DanShen Decoction targets miR-93-5p to provide protection against MI/RI by regulating the TXNIP/NLRP3/Caspase-1 signaling pathway.

Phytomedicine

December 2024

Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, PR China; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310000, PR China. Electronic address:

Article Synopsis
  • Bone marrow mesenchymal stem cells (BMSCs) exosomes have shown promise in treating heart injuries caused by ischemia/reperfusion, and this study investigates how Danshen decoction (DSD) enhances their therapeutic effects on such injuries in both lab settings and animal models.
  • * Researchers identified specific microRNAs (miRNAs) that were influenced by DSD and impacted the TXNIP signaling pathway, assessing the effectiveness of different treatments involving BMSCs-exosomes in rat models of myocardial injury.
  • * Results indicated that DSD pretreatment significantly increased the expression of certain miRNAs, particularly miR-93-5p, which in turn improved heart function and reduced cellular injury and inflammation associated with oxidative stress and apoptosis.*
View Article and Find Full Text PDF

Huangqi-Danshen decoction improves heart failure by regulating pericardial adipose tissue derived extracellular vesicular miR-27a-3p to activate AMPKα2 mediated mitophagy.

Phytomedicine

December 2024

The Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210028, China; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine Nanjing, 210028, China; Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, 210028, China. Electronic address:

Background: Huangqi-Danshen decoction (HDD) is a classic traditional Chinese medicine for treating heart failure. Pericardial adipose tissue (PAT) has recently gained increasing attention in cardiovascular diseases.

Purpose: This study aimed to investigate the effect of pericardial adipose tissue-derived extracellular vesicles on heart failure, the protective effect of HDD on myocardial remodel in heart failure rats, and identify the potential molecular mechanisms involved.

View Article and Find Full Text PDF
Article Synopsis
  • Cardiomyocyte loss and fibrosis significantly contribute to the damage caused by myocardial infarction (MI), which leads to heart dysfunction.
  • Mesenchymal stem cell (MSC)-derived exosomes, especially when combined with Danshen decoction (DSY), show potential in improving heart recovery after MI in rat models.
  • The study found that exosomes from BM-MSCs combined with DSY were more effective than standard BM-MSC exosomes in enhancing cardiac function and structure, while also reducing damage and cell death in heart cells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!